Markets:

Overview

News

Currencies

International

Treasuries

McKesson Corp (NY:MCK)

747.16 +3.49 (+0.47%)

Streaming Delayed Price Updated: 3:44 PM EDT, May 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about McKesson Corp

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

25 26 Next >

Peering Into McKesson's Recent Short Interest ↗

January 15, 2024

Via Benzinga

McKesson to Present at the 42nd Annual J.P. Morgan Healthcare Conference

January 09, 2024

From McKesson Corporation

Via Business Wire

If You Invested $1000 In This Stock 15 Years Ago, You Would Have $12,000 Today ↗

January 05, 2024

Via Benzinga

Check Out What Whales Are Doing With MCK ↗

January 03, 2024

Via Benzinga

Exceeding Expectations: McKesson Achieves Strong Performance and Rewards Investors ↗

January 02, 2024

On January 02, 2024, McKesson (NYSE:MCK) will distribute a dividend payout of $0.62 per share, equating to an annualized dividend yield of 0.55%. Shareholders who owned the stock before the ex-dividend...

Via Benzinga

McKesson Corporation Announces Third Quarter Fiscal 2024 Earnings Release Date and Participation in January Conference

December 27, 2023

From McKesson Corporation

Via Business Wire

How Is The Market Feeling About McKesson? ↗

December 25, 2023

Via Benzinga

Here's How Much You Would Have Made Owning McKesson Stock In The Last 5 Years ↗

December 18, 2023

Via Benzinga

Silver Economy Successes: 3 Stocks Benefitting From an Aging Population ↗

December 27, 2023

Explore our in-depth analysis of aging population stocks, uncovering the opportunities and challenges in this sector.

Via InvestorPlace

Topics Economy

Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug ↗

December 21, 2023

The FDA approved Calliditas Therapeutics AB's (NASDAQ: CALT) Tarpeyo (budesonide) delayed-release capsules to reduce the loss of kidney function in adults with primary immunoglobulin A nephropathy...

Via Benzinga

What 5 Analyst Ratings Have To Say About McKesson ↗

December 11, 2023

Via Benzinga

How Is The Market Feeling About McKesson? ↗

December 08, 2023

Via Benzinga

This 1 Surprising New Tailwind Is Lifting These 2 Evergreen Stocks ↗

December 04, 2023

New growth drivers are helping to propel these reliable and steady businesses.

Via The Motley Fool

Here's How Much $100 Invested In McKesson 15 Years Ago Would Be Worth Today ↗

December 01, 2023

Via Benzinga

If You Invested $1000 In This Stock 15 Years Ago, You Would Have $13,000 Today ↗

November 22, 2023

Via Benzinga

(MCK) - Analyzing McKesson's Short Interest ↗

November 22, 2023

Via Benzinga

Peering Into McKesson's Recent Short Interest ↗

November 06, 2023

Via Benzinga

Teva Pharma is the way to play the re-rise of generic drugs

November 28, 2023

Generic and specialty pharmaceutical company, Teva Pharmaceutical's stock, has underperformed for years, but a potential spinoff may be a catalyst for growth

Via MarketBeat

10 Health Care Stocks Whale Activity In Today's Session ↗

November 15, 2023

Via Benzinga

3 Biotech Stocks You’ll Regret Not Buying Soon: November 2023 ↗

November 14, 2023

The global biotechnology market could nearly triple by 2030. Investors should consider buying these biotech stocks before they explode.

Via InvestorPlace

McKesson Corp. (NYSE: MCK) Sets New 52-Week High in Friday Session

November 10, 2023

Via Investor Brand Network

Topics Economy

Analyst Ratings for McKesson ↗

November 03, 2023

Via Benzinga

McKesson Unusual Options Activity For November 01 ↗

November 01, 2023

Via Benzinga

Qualcomm, Merck And 2 Other Stocks Insiders Are Selling ↗

November 10, 2023

The Nasdaq 100 closed lower by more than 100 points on Thursday. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

3 Evergreen Stocks for Long-term Wealth Generation ↗

November 09, 2023

Finding solid long-term stocks that aren't value traps is tough, but these stocks have great fundamentals and equally compelling prospects.

Via InvestorPlace

Stock Market Rally Back In Force As Treasury Yields Plunge; Arista, Palantir Among Winners: Weekly Review ↗

November 03, 2023

Bulls are back in control as the major indexes confirmed the uptrend this week.

Via Investor's Business Daily

McKesson (MCK) Q2 2024 Earnings Call Transcript ↗

November 02, 2023

MCK earnings call for the period ending September 30, 2023.

Via The Motley Fool

Topics Earnings

McKesson Corporation Reports Fiscal 2024 Second Quarter Results and Raises Full Year Guidance

November 01, 2023

From McKesson Corporation

Via Business Wire

Top 3 Blue-Chip Stocks in the Healthcare Industry ↗

November 01, 2023

These are some of the best healthcare blue-chip stocks by market capitalization, offering great returns for investors.

Via InvestorPlace

Earnings Due For Stealth GLP-1 Weight-Loss Drug Play McKesson, Rivals ↗

November 01, 2023

McKesson earnings are on tap, with Cencora and Cardinal Health due soon.

Via Investor's Business Daily

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

25 26 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.